Clinical trial
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical…
NCT00078910 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00078910 |
|---|---|
| Title | Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer |
| Official title | A Prospective Phase II Study of Preoperative, Controlled Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | exisulind, conventional surgery, neoadjuvant therapy |
| Enrollment | 130 |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Mar 9, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: